Literature DB >> 7070224

Cardiac function in mild and severe primary hypothyroidism.

E C Ridgway, P W Ladenson, D S Cooper, G H Daniels, G S Francis, F Maloof.   

Abstract

One hundred patients with mild to severe primary hypothyroidism have been analyzed for abnormalities in left ventricular performance utilizing noninvasive techniques. These studies have revealed significant abnormalities in cardiac function which correlated inversely with serum T4 levels. The abnormalities in cardiac function were completely reversible with thyroid hormone therapy. Even in patients with mild subclinical hypothyroidism, significant changes in left ventricular performance were achieved by doses of thyroid hormone which normalized TSH secretion. Therapy with either L-T4 or L-T3 resulted in normal cardiac function though L-T3 produced normal cardiac function on lower doses than were necessary to normalize TSH secretion. These studies are intended to provide new information on the optimal treatment of hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7070224     DOI: 10.1016/0024-3205(82)90281-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS).

Authors:  A Amouzegar; M Dehghani; H Abdi; L Mehran; S Masoumi; F Azizi
Journal:  J Endocrinol Invest       Date:  2022-08-04       Impact factor: 5.467

Review 2.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

3.  A longitudinal evaluation of thyroid function in critically ill surgical patients.

Authors:  G P Zaloga; B Chernow; R C Smallridge; R Zajtchuk; K Hall-Boyer; R Hargraves; C R Lake; K D Burman
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

4.  Cardiac function in congenital hypothyroidism: impairment and response to L-T4 therapy.

Authors:  G Balducci; A Acquafredda; F Amendola; M Natuzzi; N Laforgia; L Cavallo
Journal:  Pediatr Cardiol       Date:  1991-01       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.